We always wonder that in spite of
so much noise about our IT industry’s clout in placing india as global hub for
IT solutions, none of our IT behemoths like Infosys, TCS or Wipro have ever developed
a product like Windows, IOS, Oracle. These companies operates on cheap Labour
to win business; term cheap labour because that is what most of our IT
professionals are doing in the labs of these behemoths…they just type the codes
of a program developed somewhere in USA which is as lengthy as millions of
lines.
So I am never a big investor in
indian IT companies as their model can be challenged any time by other emerging
alternatives like china and in fact these companies have realized it some time
back and now focusing for new growth avenues. Their margins are falling
continuously.
Part of the reason for not focusing
on developing an innovative IT product can be indian business structure where
very little equity money is available for investments in new innovative but
risky products as compared to developed markets. But this can further be due to
the perception about the ability of Indians to produce something unique. Some
may say that now millions of dollars are being invested in ecommerce startups
in india like Flipkart but there is nothing new on fact and that is why almost
99% will vanish. Most of these startups have stolen their ideas from advanced
USA markets and they think that their success in USA means success in india too
although we are a very different country.
Like delivery startups like
Foodpanda and Localbanya; they are trying to sell us the convenience factor in
delivery at home but we Indians have never cared about convenience. We are
always about value for money. We are ordering on Foodpanda because it is now
value for money as we are getting delivered free. So no wonder Foodpanda and
Localbanya are now at the verge of closing.
But Quick heal is the answer for
lack of product based companies in indian IT sector. KPIT is another one which I
like. Quick Heal chose the difficult path of investing in developing a product
rather than offering generic services and so now they are a brand in direct
competition to MNC behemoths like AVG, Mcafee, Norton, Kaspersky and in fact
they are giving these a run for their money because Quick Heal commands around
30% share of retail anti virus market in india.
As they were short of funds
initially so they invested lesser in branding but in developing distribution channels
across india by offering them high margins, so now they have one of the biggest
distribution strength in india with around 12000 channel partners.
Quick Heal is a 300 cr turnover
company but it invests around 50 cr in R&D which is never seen in india. It
is also spending around 30 cr in advertising these days. As it invests big in
R&D now so its margins are falling for past few years and its NP is around
60 cr in 2015. It has grown from 170 cr to 300 cr in last 5 years which is not
so fast and that is where I feel the chances of growth and reason for going for
IPO is emerging.
I never invest in IPO’s as I always
find them expensive. Quick heal is also expensive at a pe ratio of 40. Another
thing that I look for in an IPO’s is the reason for the IPO, if IPO proceeds are going to promoters as they
are selling their stake, I take this as a big negative. But if promoters are not getting
any money and in fact company is issuing new shares and the funds collected
will be used for the growth of company, that is a very healthy sign of the
inherent strength and growth prospects in the company.
In this IPO promoters are not
getting anything only their equity investor sequoia is selling part of their share and company will get
around 250 cr for future growth. They have plan for using 111 cr for branding
and 40 cr for R&D which are a big positive. Their work force is around 1500
out of which 550 is dedicated for R&D which is just great.
Quick Heal is very dominant in Home
and small user segment of security but they are now focusing big on SME (small
and medium enterprises) and large enterprises segment and also launched their
solution “Seqrite” which can be a big surprise in the future so as their focus
on cloud, Internet of things sector.
I am a bit late in posting on this
as I have spent only a few hours on this. But I feel at 40 pe ratio this one is
worth taking a risk as this is different from any other IT company we have seen
so far and so should not be compared with them. They are offering this at 40 pe
ratio may be because of no so fast growth in the recent years. Also for product based companies, PE is not the only metric to value them, turnover based valuation along with PE is the best as product based companies can quickly earn bigger percentage of their revenue as profits after they cross a critical scale. Quick Heal is investing big (around 20% of turnover) in R&D, the full benefits of which are yet to achieved; may be mainly due to lack of sales promotion and branding which it plans to invest in now. After it reaches a scale of 500-600 cr (of current products, not of any future products) we can see a big turnaround in profits.
Even if it falls after listing I would be willing to invest more into this. I am a great believer in the strength of intellect and creativity of we Indians and have faith that we have all the muscles to compete at global scale in branded products. Digital india and growth of IT gadget are a big opportunity for security system business in india.
Even if it falls after listing I would be willing to invest more into this. I am a great believer in the strength of intellect and creativity of we Indians and have faith that we have all the muscles to compete at global scale in branded products. Digital india and growth of IT gadget are a big opportunity for security system business in india.
(Views are personal and should not be taken as a recommendation for buying or selling a stock. Stock markets are inherently risky so kindly do your Due Diligence before investing. I am not a certified Sebi Analyst and holding the shares discussed in this Post)
Good one....I could not have thought the same way despite of being an IT literate....
ReplyDeleteThanks Brother
DeleteDear sir, Good to see you after a long time. Titan Bio can be bought at any price provided it shows growth in the topline (not normal but high growth like 50%. This Dec-15 quarter they have grown from 8 cr to 11.50 cr which is good. It is trading in tight zone of 35-45 with a bit higher valuations although at a market cap of just 30 cr. Traded quantity is always low So buying at this level is not suggested unless it shows consistent growth in topline. if it grows like this for 2-3 qtrs then it is a buy even at 50. However at this level, there are much better high quality stocks available at cheap valuations...so better to go for them.
ReplyDeleteRegards
Dear Sir, i did not get anything at IPO but last day bought some at 266.It is hammered due to bad press on the listing day due to Malani and Tax notices issues. The timing of complain on the listing day looks doubtful by Malani...he could have filed much earlier.
ReplyDeleteIt may have further variable bounces but just took a small chance :)